Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-18-000476
Filing Date
2018-01-16
Accepted
2018-01-16 08:57:09
Documents
5
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A vtvt-10ka_20161231.htm 10-K/A 148122
2 EX-31.1 vtvt-ex311_6.htm EX-31.1 17183
3 EX-31.2 vtvt-ex312_7.htm EX-31.2 17267
4 EX-32.1 vtvt-ex321_8.htm EX-32.1 7015
5 EX-32.2 vtvt-ex322_9.htm EX-32.2 6969
  Complete submission text file 0001564590-18-000476.txt   197644
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37524 | Film No.: 18527465
SIC: 2834 Pharmaceutical Preparations